3NHLBI/ WHO workshop. Global strategy for asthma management and prevention. National Institutes of Health, National Heart, Lung and Blood Institute, 1994,20- 37.
4Takasski J, Kamohara M, Matsumoto M, et al. The molecular characterization and tissue distrbution of the human cysteinyl leukotriene CysLT(2) receptor. Biochem Biophys Res Commun,2000,274: 316-322.
5Ferreira MB, Santos AS, Pregal AL, et al. Leukotriene receptor antagonists (Montelukast) in the treatment of asthma crisis: preliminary results of a double-blind placebo controlled randomized study. Allerg Immunol (Paris) ,2001,33: 315-318.
6National Heart, Lung, and Blood Institute National Institutes of Health: Global Strategy for Asthma Management and Prevention,Revised, 2002.65-85.
